Hero background

Cancer Immunotherapy - MSc

Holloway Campus, United Kingdom

Masters Degree / 12 months

20000 £ / years

Overview

Why study this course?


Our Cancer Immunotherapy master's will teach you about conventional cancer therapies including surgery, radiation and chemotherapy. You’ll have access to highly qualified researchers and teachers in pharmacology and immunology, as well as those from our Cellular and Molecular Immunology Research Centre. We’ll encourage you to join professional societies so you can improve your CV and build upon the impressive skills you’ll already have developed from research projects on the course. By the end of this postgraduate course, you’ll come to understand why investigators and oncologists now believe immunotherapy combined with pharmacological treatments will soon provide curative therapies that can give patients a new lease of life.


Read more about this course 


The Cancer Immunotherapy MSc will introduce you to the advancement of treatments that are fighting to prolong the lives of cancer patients. Cancer is increasing worldwide, and by 2030 there are expected to be 22 million new cases per year. By the end of this course, you’ll be ready for employment as a professional who can help to tackle this global challenge.

We’ll provide you with an in-depth understanding of the molecular targets at which the different classes of anticancer drugs are aimed, as well as the current evolution of drug therapies. This will help you review the biology of cancer, taking pathological considerations into account, and the molecular changes within cells which are associated with the progression of the disease.

You’ll enhance your intellectual and practical skills necessary for the collection, analysis, interpretation and understanding of scientific data. This means you’ll cover new areas in immunotherapy as well as existing pharmacological therapies including (but not limited to) monoclonal antibodies in cancer therapy and prevention; DNA vaccines against cancer; adoptive T cell therapy; dendritic cell vaccines; microbial causes of cancer; adjuvant development for vaccines; epigenetics and cancer; immuno-chemotherapy; dendritic cell vaccine development; the ageing immune system and immunotherapy; natural killer cells/tumour-associated macrophages and cancer immunotherapy and Exosomes and Microvesicles (EMVs) in cancer therapy and diagnosis.

The teaching is delivered by highly-qualified researchers and teachers in pharmacology and immunology, including those from our Cellular and Molecular Immunology Research Centre. Skills gained from research projects will be highly marketable in industry, academia and the National Health Service (NHS), and you’ll also be encouraged to join the British Society of Immunology and the International Society of Extracellular Vesicles.

Similar Programmes

Medical Microbiology and Immunology

Medical Microbiology and Immunology

location

University of Toledo, Toledo, United States

Earliest Intake

June 2025

Gross Tuition

33700 $

Master of Optometry MOptom

Master of Optometry MOptom

location

University of Bradford, Bradford, United Kingdom

Earliest Intake

June 2024

Gross Tuition

24456 £

Health Sciences

Health Sciences

location

Texas State University, San Marcos, United States

Earliest Intake

February 2025

Gross Tuition

24520 $

Leadership in Health and Social Care (International) (Distance Learning) MSc

Leadership in Health and Social Care (International) (Distance Learning) MSc

location

University of Bradford, Bradford, United Kingdom

Earliest Intake

August 2024

Gross Tuition

19494 £

Medical and Health Professions Education

Medical and Health Professions Education

location

Prifysgol Bangor University, Bangor, United Kingdom

Earliest Intake

May 2025

Gross Tuition

19500 £

0

Give us some starts:

top arrow

TOP